Southern Copper Corp. (0L8B)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 194.35 |
|---|---|
| 52-week range | 118.99 – 227.23 |
| Return, 1 month / 3 months | −3.9% / +12.0% |
| Return, 1 year / 3 years | +55.8% / +222.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 50.9% |
| Worst drawdown (1 year) | -30.3% |
| Average daily value traded | 0.41M USD |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Southern Copper Corp. is a mining company that produces copper, mainly from mines it operates in Peru and Mexico. It also recovers by-products from its mining and refining operations, including molybdenum, zinc, silver and gold. The company runs open-pit mines, concentrators, smelters and refineries, and its customers are industrial users of refined metals around the world. Its headquarters are in the United States, while its mining and processing operations are based in Latin America.
The shares are listed on the London Stock Exchange in UK under the code 0L8B, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Southern Copper Corp. (0L8B) trades on the London Stock Exchange in UK. It last closed at USD 194.35 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,384 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 55.8% and over the last three months it rose 12.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.0% | ||
| From 52-week high | -11.0% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.0% | ||
| 6-month return | 12.2% | ||
| 12-month return, skipping the last month | 62.1% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.3% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.41M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.4% |
|---|---|
| 1 month | −3.9% |
| 3 months | +12.0% |
| 6 months | +12.2% |
| 1 year | +55.8% |
| 3 years | +222.9% |
| 5 years | +318.6% |
Signals
| 50-day / 200-day average | 201.05 / 185.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | USD 1.1000 |
| 13 May 2026 | USD 1.0100 |
| 9 Feb 2026 | USD 1.0221 |
| 11 Nov 2025 | USD 0.9000 |
| 14 Aug 2025 | USD 0.8247 |
| 2 May 2025 | USD 0.7069 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.